PHK
KALA icon

Point72 Hong Kong’s KALA BIO KALA Stock Holding History

Point72 Hong Kong’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-4
Closed -$54K – 2225
2021
Q2 		$54K Buy
+4
New +$62.9K ﹤0.01% 1453
2021
Q1 		– Hold
0
– – – 1726
2020
Q4 		– Hold
0
– – – 1645
2020
Q3 		– Sell
-3
Closed -$77K – 1360
2020
Q2 		$77K Buy
+3
New +$85K 0.01% 679
2020
Q1 		– Sell
-1
Closed -$5K – 1151
2019
Q4 		$5K Buy
+1
New +$9.66K ﹤0.01% 1040
2019
Q1 		– Hold
0
– -$3K – 1147
2018
Q4 		– Hold
0
– – – 694

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Point72 Hong Kong's KALA Position: Q3 2021 in Review

Point72 Hong Kong sold out of KALA BIO (KALA) in Q3 2021, closing a stake of 4 shares — an estimated $54K sold.

Point72 Hong Kong first reported a position in KALA in Q4 2019 and held it in 3 quarters. The position peaked at $77K in Q2 2020. 99 funds tracked by Wall St. Rank hold KALA as of Q3 2021.

  • Point72 Hong Kong reported no remaining KALA BIO position as of Q3 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 4 KALA BIO shares in Q3 2021, an estimated $54K.
  • Point72 Hong Kong first reported a position in KALA BIO in Q4 2019 and held it in 3 quarters.
  • Point72 Hong Kong's KALA BIO position peaked at $77K in Q2 2020.
  • 99 funds tracked by Wall St. Rank held KALA BIO as of Q3 2021.

Based on Point72 Hong Kong's 13F filing for Q3 2021, filed 15 Nov 2021.